Huaren Pharmaceutical: Notice on the Wholly-owned Subsidiary Peritoneal Dialysis Solution (Lactate-G 4.25%) Obtaining an Approval Notice for Drug Supplementation Applications

SZSI · Apr 29

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.